Background Image
Biomet
One Surgeon. One Patient.
 

Plasmax™: Lower Abdomen - General

Some of the information contained on this webpage pertains to products, indications for use of products and/or therapies that are only available outside the United States and have not been approved or cleared for marketing by the United States Food & Drug Administration.

Shekarriz B, Stoller ML. The use of fibrin sealant in urology. J Urol 2002;167(3):1218- 25.

Summary: Reviews the available literature regarding the use of fibrin sealant and discusses possible areas for its use in urology, including renal surgery, ureteral surgery, fistula repair, and surgery for infertility.

Quotation: “Fibrin sealant is an effective and safe topical agent for controlling surface bleeding during elective and trauma related urological procedures.”

“Fibrin sealant has proved to be an effective hemostatic agent in several surgical fields, including cardiovascular, thoracic, and abdominal surgery.”

PubMed ID: 11832701


Hanks JB, Kjaergard HK, Hollingsbee DA. A comparison of the haemostatic effect of Vivostat patient-derived fibrin sealant with oxidized cellulose (Surgicel) in multiple surgical procedures. Eur Surg Res 2003;35(5):439-44.

Summary: In a prospective, randomized, multicenter clinical study, the hemostatic abilities of an autologous fibrin sealant and Surgicel oxidized cellulose were compared in cardiothoracic, general, obstetric and gynaecologic, and vascular surgery. Autologous fibrin sealant use resulted in a significantly shorter time to hemostasis and more successful cases.

Quotation: “… patient-derived sealant is a more reliable and rapidly effective means of controlling bleeding than Surgicel in a wide range of surgical procedures.”

PubMed ID: 12928602


© Copyright 2009 Biomet, Inc. All rights reserved.
Background Image